Research team finds reason mothers rarely pass COVID-19 virus to fetus – The South End

Why are newborns born to mothers with COVID-19 rarely infected? Researchers at the Wayne State University School of Medicine and the Perinatology Research Branch of National Institute of Child Health and Human Development/National Institutes of Health in Detroit have found that placental cells minimally express the instructions, or mRNA, to generate the cell entry receptor and protease required by the virus that causes COVID-19 to invade human cells.

The pandemic caused by SARS-CoV-2 has infected more than 10 million people worldwide, including pregnant women, yet to date there is no consistent evidence that pregnant mothers pass the virus to their newborns.

While pregnant women represent a potential high-risk population given that other viral infections such as Zika, cytomegalovirus and rubella can be passed from mother to fetus, the evidence for vertical transmission of SARS-CoV-2 is rare, and acquisition of the virus in the nursery cannot be excluded.

A requirement for a virus to infect a cell is that cell surface expresses a receptor for the virus. The main receptor for the new coronavirus is the angiotensin converting enzyme 2, or ACE2. The spike protein of the virus the spikes seen in the images of the virus is activated by an enzyme called TMPRSS2. Cells that co-express ACE2 and TMPRSS2 such as those found in the lungs are particularly vulnerable to infection.

In the study Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?, published today in the journal eLife,WSU and PRB researchers employed cutting-edge molecular techniques such as single-cell genomics to determine whether human placental cells express the mRNA for the mediators that the virus SARS-CoV-2 uses for entry into the cell. The researchers concluded that placental cells do not express the transcripts needed to develop the receptors that the virus requires to facilitate vertical transmission from mother to the fetus.

The findings of this study help to understand why mother-to-fetus transmission is so rare (less than 2% of cases), said Roberto Romero, M.D., D.Med.Sci, chief of the PRB. The most likely explanation is that the cellular instructions for the production of the main receptor for SARS-CoV-2 are not expressed in the human placenta. In contrast, the receptors for other viruses known to cause fetal infection such as Zika and cytomegalovirus were found in placental cells.

Roger Pique-Regi, Ph.D., assistant professor of the WSU Center for Molecular Medicine and Genetics, and of Obstetrics and Gynecology, first author of the study, explained that the single-cell genomics technology the researchers employed allows them to study the transcriptome of individual cells isolated in tiny oil droplets using microfluidics.

This allows us to obtain at an unprecedented level of detail the multiple different cell types and the genes being expressed in gestational tissues, said Dr. Pique-Regi, head of the Single-Cell Genomics Section of the PRB. Here, we have dissected at the molecular level the different cell types of the human placenta across trimesters, and the membranes enveloping the fetus in the third trimester. This allowed us to determine which cell types are present and if they express the genes necessary for viral infection and spreading.

While the study allows the possibility that SARS-CoV-2 could infect the placenta via alternate entry routes while interacting with other proteins, the findings provide strong evidence that it is unlikely to infect the placenta and fetus through the traditional cell entry mediators.

Single-cell and single-nucleus RNA sequencing allowed us to investigate the expression of the main cell entry mediators for SARS-CoV-2 by the human placenta throughout pregnancy, said Nardhy Gomez-Lopez, Ph.D., associate professor of the WSU Department of Obstetrics and Gynecology and head of the Immunobiology Section of the PRB. Our findings revealed that the human placenta lacks expression of such mediators, providing an explanation for the paucity of vertical transmission in pregnant women with COVID-19. Yet, placental cells do express the receptors for other viruses such as Zika, cytomegalovirus and rubella, explaining why some infections affect the fetus and others are unlikely to do so.

Other members of the research team include Adi Tarca, Ph.D., professor of WSU Obstetrics and the Gynecology, Bioinformatics and Computational Biology Unit of the WSU School of Medicine Perinatal Initiative; Francesca Luca, Ph.D., associate professor of WSU Molecular Medicine and Genetics, and of Obstetrics and Gynecology; Yi Xu, PRB research associate; Adnan Alazizi, Center for Molecular Medicine and Genetics researcher; Yaozhu Leng, PRB research assistant; and Chaur-Dong Hsu, M.D., chair and Frank P. Iacobell Professor of WSU Obstetrics and Gynecology.

A video of the study is available here.

Visit link:

Research team finds reason mothers rarely pass COVID-19 virus to fetus - The South End

Interpace Announces Acceptance of Seminal Clinical Validation Study for Thyroid Assays – GlobeNewswire

Podium Presentation Accepted for the American Society of Cytopathology (ASC) Annual Meeting

PARSIPPANY, NJ, July 21, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that a peer-reviewed manuscript describing results from a seminal clinical validation study of the combination of ThyGeNEXT and ThyraMIR has been accepted for publication in the highly respected journal, Diagnostic Cytopathology. The study, led by Dr. Mark Lupo from the Thyroid and Endocrine Center of Florida, reported on the ability of the combination of ThyGeNEXT/ThyraMIR tests to successfully stratify nearly 200 indeterminate thyroid nodules for risk of malignancy. Sites participating in this multicentered study included Cedars-Sinai Medical Center, Jackson Thyroid & Endocrine Clinic, University of Michigan, Massachusetts General Hospital/Harvard Medical School, and the University of Arkansas for Medical Sciences.

According to Jack Stover, President and CEO of Interpace, Were excited that this important study will soon be published in such a prominent peer reviewed journal and will be further highlighted at the ASC Annual Meeting in November. He continued We look forward to sharing these results with the physician and payer communities shortly.

About ThyGeNEXT and ThyraMIR

ThyGeNEXT is Interpaces most recent next generation sequencing test that was expanded from its original version (ThyGenX) to include markers that have targeted therapies and those that can identify aggressive forms of thyroid cancer.

ThyGeNEXT utilizes state-of-the-art next-generation sequencing (NGS) to identify more than 100 genetic alterations associated with papillary and follicular thyroid carcinomas, the two most common forms of thyroid cancer, as well as Medullary Thyroid Carcinoma. ThyraMIR is the first microRNA gene expression classifier. MicroRNAs are small, non-coding RNAs that bind to messenger RNA and regulate expression of genes involved in human cancers, including every subtype of thyroid cancer. ThyraMIR measures the expression of 10 microRNAs. Both ThyGeNEXT and ThyraMIR are covered by Medicare and Commercial insurers, with more than 280 million members covered.

According to the American Thyroid Association, approximately 20% of the 525,000 thyroid fine needle aspirations (FNAs) performed on an annual basis in the U.S. are indeterminate for malignancy based on standard cytological evaluation, and thus are candidates for ThyGeNEXT and ThyraMIR.

ThyGeNEXT and ThyraMIR reflex testing yields high predictive value in determining the presence and absence of cancer in thyroid nodules. The combination of both tests can improve risk stratification and surgical decision-making when standard cytopathology does not provide a clear diagnosis.

About Interpace Biosciences

Interpace Biosciences is an emerging leader in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications.

Clinical services, through Interpace Diagnostics, provides clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. Interpace has four commercialized molecular tests and one test in a clinical evaluation process (CEP): PancraGEN for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts; ThyGeNEXT for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay; ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay; and RespriDX that differentiates lung cancer of primary vs. metastatic origin. In addition, BarreGEN for Barretts Esophagus, is currently in a clinical evaluation program whereby we gather information from physicians using BarreGEN to assist us in positioning the product for full launch, partnering and potentially supporting reimbursement with payers.

Pharma services, through Interpace Pharma Solutions, provides pharmacogenomics testing, genotyping, biorepository and other customized services to the pharmaceutical and biotech industries. Pharma services also advance personalized medicine by partnering with pharmaceutical, academic, and technology leaders to effectively integrate pharmacogenomics into their drug development and clinical trial programs with the goals of delivering safer, more effective drugs to market more quickly, and improving patient care.

For more information, please visit Interpace Biosciences website at http://www.interpace.com.

About ASC

The American Society of Cytopathology (ASC), founded in 1951, is a 3,000 member distinguished national professional society of physicians, cytotechnologists and scientist who are dedicated to the cytologic method of diagnostic pathology. The ASCs diverse membership includes representatives from other countries who share a vision of education, research and continuous improvement in the standards and quality of patient care. The ASC is a unique society that provides a forum where physicians and cytotechnologists can interact and network with each other on both a personal and professional level.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, relating to the Companys future financial and operating performance. The Company has attempted to identify forward looking statements by terminology including believes, estimates, anticipates, expects, plans, projects, intends, potential, may, could, might, will, should, approximately or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Companys control. These statements also involve known and unknown risks, uncertainties and other factors that may cause the Companys actual results to be materially different from those expressed or implied by any forward-looking statement, including the adverse impact of the Coronavirus (COVID-19) pandemic, our history of operating losses and the limited revenue generated by our clinical and pharma services customers, our dependence on sales and reimbursements from our clinical services, our reliance on third parties to process and transmit claims to payers for our clinical services, and any delay, data loss, or other disruption in processing or transmitting such claims could have an adverse effect on our revenue and financial condition, our revenue recognition being based in part on our estimates for future collections which estimates may prove to be incorrect, that we will be able to meet our revenue projections and that there is no guarantee that we will be successful in completing development or realize any revenue or benefit from our efforts to launch a new product line of antibody testing of the COVID-19 virus. Additionally, all forward-looking statements are subject to the Risk Factors detailed from time to time in the Companys most recent Annual Report on Form 10-K filed on April 22, 2020, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contacts: Investor RelationsEdison Group Joseph Green(646) 653-7030 jgreen@edisongroup.com

Go here to see the original:

Interpace Announces Acceptance of Seminal Clinical Validation Study for Thyroid Assays - GlobeNewswire

Lakewood-Amedex Therapeutics Announces the Election of Peter B. Corr, Ph.D., as Chairman of the Board of Directors – PRNewswire

SARASOTA, Fla., July 21, 2020 /PRNewswire/ --Lakewood-Amedex Therapeutics Inc. (the "Company"), a clinical-stage development company of revolutionary antimicrobial Bisphosphocin pharmaceuticals for rapid localized treatment of serious antibiotic-resistant and antifungal infections, today announced that Peter B. Corr, Ph.D., has been elected as Chairman of the Board of Directors of the company. Dr. Corr assumes the role from Steve Parkinson, who continues to serve as President and CEO.

Dr. Corr, a pharmaceutical industry veteran of more than 26 years, will help guide the company as it completes a private financing underway and advances its clinical programs using antimicrobial Bisphosphocins for the treatment of serious infections of the lungs, bladder, skin and other tissues, including those caused by antibiotic-resistant bacteria, yeast and fungi.

Dr. Corr, who untilDecember 2006, served as Senior Vice President for Science and Technology of Pfizer Inc., and also headed up worldwide pharmaceutical research and development for Pfizer, previously served as Executive Vice President, Pfizer Global Research & Development and President, Worldwide Development. He also served as Senior Vice President, Discovery Research, at Monsanto/Searle and then, President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis.

Dr. Corr isCo-Founder and Managing General Partner of Auven Therapeutics Management LLLP., and was Chairman of the Board of Directors for ADC Therapeutics, S.A., founded by Auven, from its inception in 2011 through the completion of its upsized $267 million initial public offering in May, 2020. Dr. Corr is Founder and Chairman of the Board of Imvax Inc., a research and development company focused on cancer with an initial emphasis on glioblastoma and other solid tumors.

In addition, Dr. Corr has served as Chairman of the Science & Regulatory Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA); Chairman of the PhRMA Foundation Board of Directors; and Chairman of the Hever Group for six years, representing Chief Scientific Officers (CSO's) across the European and U.S. based pharmaceutical industry. He is a former Governor of the New York Academy of Sciences (and previous Chairman of the Board of Governors). Additionally, he was Chairman of the Board of the International Partnership for Microbiocides and Chairman of the Board of Directors for the Critical Path Institute. He served as a founding member of the Board of Directors of Furiex Pharmaceuticals, Inc., until the sale of the company in 2014. He is a Founder and Chairman Emeritus of the Board of Patient Assist VI which provides medicines to indigent patients in the U.S. Virgin Islands. He currently serves on the National Council for Washington University School of Medicine.

Dr. Corr received his doctorate from Georgetown University School of Medicine and spent 18 years as a researcher in molecular biology and pharmacology at Washington University, St. Louis, ultimately becoming Professor, Department of Medicine (Cardiology) and Professor, Department of Pharmacology and Molecular Biology. His research has been published in more than 160 scientific manuscripts. Dr. Corr is the recipient of numerous awards and honors.

Steve Parkinson, President and CEO of Lakewood-Amedex, commented, "We are excited to have such an accomplished industry veteran of Dr. Corr's stature assume the role of Chairman of Lakewood-Amedex Therapeutics. Dr. Corr's great experience in three major pharmaceutical companies, now all part of Pfizer, means he truly understands the growing problem of microbial resistance and the need for new antimicrobials and antifungals to fight this major threat. Dr. Corr will certainly guide us in the right direction."

Dr. Corr commented, "I have long recognized, and can't overstate, the importance of bringing novel antimicrobial products to market to fight the growing threat from antimicrobial resistance. I have been helping the Company over the last 18 months due to the importance of their work. I look forward to working formally with the team at Lakewood-Amedex to advance the exciting clinical pipeline of Bisphosphocin products and to establishing the company as a leader in the field. The developments being made at Lakewood-Amedex will, I believe, be of immense importance to the world, as evidenced recently, by the $1 billion commitment of several major pharmaceutical companies to this area."

About Lakewood-Amedex Therapeutics Inc.Lakewood-Amedex Therapeutics is a clinical stage pharmaceutical company developing a broad portfolio of anti-infective products, including first-in-class antimicrobial compounds. The company's products and technology are covered by an extensive patent portfolio consisting of granted and/or issued patents and pending patent applications covering many major pharmaceutical markets. The company's lead therapeutic candidate is a novel synthetic broad-spectrum antimicrobial proven to be effective in killing a wide range of Gram-positive, Gram-negative and antibiotic-resistant bacteria and fungi and has recently completed a Phase 2 clinical trial in patients with infected diabetic foot ulcers.

ContactsTiberend Strategic Advisors, Inc.InvestorsMiriam Miller(212) 375-2694[emailprotected]

MediaJohanna Bennett(212) 375-2686 [emailprotected]

SOURCE Lakewood-Amedex Inc.

The rest is here:

Lakewood-Amedex Therapeutics Announces the Election of Peter B. Corr, Ph.D., as Chairman of the Board of Directors - PRNewswire

Largest-Ever Study of Prostate Cancer Genomics in Black Patients IDs Potential Targets for Precision Therapies – UroToday

San Francisco, CA (UroToday.com) -- Black men in the United States are known to suffer disproportionately from prostate cancer, but few studies have investigated whether genetic differences in prostate tumors could have anything to do with these health disparities.

Now, in the largest study of its kind to date, researchers from BUSM, UC San Francisco (UCSF), and Northwestern University have identified genes that are more frequently altered in prostate tumors from men with African ancestry compared to other racial groups, though the reasons for these differences is not known, the authors say. None of the individual tumor genetic differences that were identified are likely to explain significant differences in health outcomes or to prevent Black patients from benefiting from a new generation of precision prostate cancer therapies, the authors say, as long as the therapies are applied equitably.

The newly identified gene variants could potentially lead to precision prostate cancer therapies specifically focused on men with African ancestry, and will inform broader efforts by the National Cancer Institutes RESPOND study to link gene variants to health outcomes in an even larger cohort of Black patients nationwide.

Despite declines in mortality related to cancer in the U.S., disparities by race have persisted. One in every six Black Americans will be diagnosed with prostate cancer in their lifetime, and these men are twice as likely to die from the disease as men of other races. But it is not yet clear to researchers whether differences in prostate cancer genetics contribute to these health disparities in addition to the social and environmental inequities known to drive poorer health outcomes across the board.

To date, studies trying to figure out what genes are commonly mutated in prostate cancers often have had very few samples from racial/ethnic minority groups despite the greater burden of prostate cancer in these populations. In May, the FDA approved a class of drugs known as PARP inhibitors as a therapy for men with prostate cancers driven by specific genetic mutations, but it is not known how prevalent these mutations are in people with African ancestry. As more genetic health studies are performed in minority populations, it has become clear that other genetically targeted therapies that have been developed based on studies of predominantly white patients are at times much less effective, and in some cases cause dangerous side-effects, in other racial and ethnic groups.

In the new study, published online July 10, 2020 in Clinical Cancer Research, a journal of the American Association for Cancer Research, the research team set out to better understand differences in the mutations driving prostate cancer tumors in Black versus white patients, and whether any such differences could influence disease outcomes or the effectiveness of PARP inhibitors or other targeted therapies.

The researchers collected and analyzed DNA sequencing data from previously published studies and from a commercial molecular diagnostics company. In total, they examined mutational patterns in prostate cancers from more than 600 Black men, representing the largest such study of this population to date.

The team found that the frequency of mutations in DNA repair genes and other genes that are targets of current therapeutics are similar between the two groups, suggesting that at least these classes of current precision prostate cancer therapies should be beneficial in people of both African and European ancestry, according to corresponding author Franklin Huang, MD, PhD, an assistant professor in UCSFs Division of Hematology/Oncology and member of the UCSF Helen Diller Family Comprehensive Cancer Center, UCSF Institute for Human Genetics, and UCSF Bakar Computational Health Sciences Institute.

While the researchers found no significant differences in frequencies of mutations in genes important for current prostate cancer therapies, they did identify other genes, such as ZFXH3, MYC, and ETV3, that were more frequently mutated in prostate cancers from Black men.

Developing a comprehensive understanding of how tumor genomics and other biological factors interact with social and environmental inequities to drive poorer clinical outcomes for Black prostate cancer patients should be an important priority for the efforts to improve precision medicine for these patients, the researchers say.

These types of studies will remain important to understand when certain therapies may preferentially benefit Black patients, who continue to remain underrepresented in clinical trials, Dr. Campbell said.

In particular, the results will inform the efforts of the NCI-funded RESPOND Study. RESPOND provided funding for the new UCSF-BUSM-Northwestern study to guide its efforts to perform targeted gene sequencing in tumors from an even larger cohort of Black prostate cancer patients, said Huang, who leads RESPONDs tumor genetics studies based at UCSF. Through partnerships with Black communities across the country, RESPOND aims to recruit 10,000 Black prostate cancer patients in an effort to better understand the drivers of the diseases outsize burden among Black Americans.

Previous studies have looked in isolation at different biological, social and environmental drivers of well-known racial disparities in prostate cancer, Dr. Huang said. RESPOND is a nationwide effort to integrate all these components and ultimately identify specific steps that can be taken to eliminate prostate cancers unequal burden in Black communities.

Authors: The studys lead authors are Yusuke Koga of BUSM, Hanbing Song of UCSF, and Zachary Chalmers of Northwestern University. Additional authors are Elad Ziv of UCSF; Justin Newberg and Garrett M. Frampton of Foundation Medicine, in Cambridge; Eejung Kim and Daphnee Piou of the Broad Institute of MIT and Harvard; Jian Carrot-Zhang and Matthew Meyerson of the Broad Institute and Dana-Farber Cancer Institute; Paz Polak of Mt. Sinai School of Medicine in New York; and Sarki Abdulkadir of Northwestern University.

Funding: The study was supported by the U.S. Department of Defense (W81XWH-17-PCRP-HD); the U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) (P20 CA233255-01, U19 CA214253); and the Prostate Cancer Foundation.

Source: "Largest-Ever Study Of Prostate Cancer Genomics In Black Patients Ids Potential Targets For Precision Therapies | School Of Medicine". 2020.Bumc.Bu.Edu.

Related Content:

Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.

Read more from the original source:

Largest-Ever Study of Prostate Cancer Genomics in Black Patients IDs Potential Targets for Precision Therapies - UroToday

Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets – PRNewswire

SYDNEY and LOS ANGELES, July 21, 2020 /PRNewswire/ --Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop new targeted theranostic (diagnostic and therapy) products for a broad range of cancer types.

Clarity and ImaginAb will combine their proprietary technologies to develop novel minibody and cys-diabody radiopharmaceutical products using Clarity's copper chelators to fully exploit the benefits of the theranostic pairing of copper-64 or copper-67.

ImaginAb's CEO, Ian Wilson, said, "ImaginAb designs and engineers small, highly targeted proteins known as minibodies and cys-dibodies coupled with radioisotopes to image important molecular targets using standard Positron Emission Tomography (PET). We are excited to work together with Clarity on expanding the utility of ImaginAb's technologies and entering the field of targeted radiotherapy."

Dr Alan Taylor, Clarity's Executive Chairman, commented, "This collaboration will enable us to bring together ImaginAb's unique expertise in designing minibodies, which are used to ensure rapid and highly specific targeting of tumours, with Clarity's chelator technology, which will allow us to fully exploit the perfect pairing of copper-64 for diagnosis and copper-67 for therapy."

"The teams at Clarity and Imaginab are already working together to explore the synergies of combining their expertise in lead generation, manufacture, regulatory frameworks and clinical development to fast-track new theranostic products which will be the future of therapy. Combined, the companies will pursue their ultimate goal of developing better treatments for children and adults with cancer", Dr Taylor added.

About Clarity Pharmaceuticals

Clarity is a personalised medicine company focused on the treatment of serious diseases. The Company is a leader in innovative radiopharmaceuticals, developing targeted therapies for the treatment of cancer and other serious diseases in adults and children.

http://www.claritypharmaceuticals.com

About ImaginAb

ImaginAb Inc. is an immuno-oncology imaging company focused on providing actionable insight into patient selection and treatment progress for cancer immunotherapy, enabling precision medicine. ImaginAb engineers antibody fragments called minibodies that maintain the exquisite specificity of full-length antibodies while remaining biologically inert in the body. Used with widely available PET scan technology, these novel minibodies illuminate high-value molecular targets, providing physicians with a whole-body picture of immune activity. ImaginAb is advancing a pipeline of minibodies against oncology and immunology targets including the CD8 ImmunoPET targeting CD8 cells. ImaginAb's products have the potential to improve patient care and lower healthcare costs. The Company is backed by top tier venture capital firms and strategic corporate firms including The Parker Institute for Cancer Immunotherapy , Adage Capital, The Cycad Group, Merck (MSD) Pharma, Novartis Bioventures and Jim Pallotta of the Raptor Group.

For more information about ImaginAb's pipeline and technology, visit http://www.imaginab.com.

SOURCE Clarity Pharmaceuticals

http://www.claritypharmaceuticals.com

Read more:

Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets - PRNewswire

Sweden hoped herd immunity would curb COVID-19. Don’t do what we did. It’s not working. – USA TODAY

Coronavirus pandemic has been defeated in other nations but not in America. CDC needs White House to provide the leadership, says Dr. David Satcher. USA TODAY

Sweden's approach to COVID has led to death, grief and suffering. The only example we're setting is how not to deal with a deadly infectious disease.

Sweden has often been considered a leader when it comes to global humanitarian issues, regarded as a beacon of light in areas such asaccepting refugees and working against global warming. In the COVID-19 pandemic, Sweden has also created interest around the world by following its own path of using a soft approach not locking down, introducing mostly voluntary restrictions and spurning the use of masks.

This approach has been perceived as more liberal and has shown up in Be Like Sweden signs and chants at U.S. protests.Wherever measures have been lenient, though, death rates have peaked. In the United States, areas that are coming out of lockdown early are suffering, and we are seeing the same in other countries as well.

The motives for the SwedishPublic Health Agency's light-touch approach are somewhat of a mystery. Some other countries that initially used this strategy swiftly abandoned it as the death toll began to increase, opting instead for delayed lockdowns. But Sweden has been faithful to its approach.

Why? Gaining herd immunity, where large numbers of the population (preferably younger) are infected and thereby develop immunity, has not been an official goal of the Swedish Public Health Agency. But it has said immunity in the population could help suppress the spread of the disease, and some agency statements suggest it is the secret goal.

Further evidence of this is thatthe agency insists on mandatory schooling for young children, the importance of testing has been played down for a long time, the agency refused to acknowledge the importance of asymptomatic spread of the virus (concerningly, it hasencouraged those in households withCOVID-19 infected individuals to go to work and school) and still refuses to recommend masks in public, despite the overwhelming evidence of their effectiveness. In addition, the stated goal of the Swedish authorities was always not to minimize the epidemic, but rather slow it down, so that the health care system wouldnt be overwhelmed.

People outside a restaurant without masks or social distancing on July 17, 2020 in Gotland, Sweden.(Photo: Martin von Krogh/Getty Images)

Several authorities, including the World Health Organization, have condemned herd immunity as a strategy. "It can lead to a very brutal arithmetic that does not put people and life and suffering at the center of that equation, Dr. Mike Ryan, executive director of WHO'sHealth Emergencies Program, said at a press conference in May.

With COVID-19, dont only focus on death: Too many Americans are alive and in misery.

Regardless of whetherherd immunity is a goal or a side effect of the Swedish strategy, how has it worked out? Not so well, according to the agencys own test results. The proportion of Swedes carrying antibodies is estimated to beunder 10%, thus nowhere near herd immunity. And yet, the Swedish death rate is unnerving. Sweden has a death toll greater than the United States: 556 deaths per million inhabitants,compared with 425, as of July 20.

Sweden also has a death toll more than four and a half times greater than that of the other four Nordic countries combined more than seven times greater per million inhabitants. For a number of weeks, Sweden has been among the top in the world when it comes to current reported deaths per capita. And despite this, the strategy in essence remains the same.

It is possible that the Public Health Authority actually believed that the Swedish approach was the most appropriate and sustainable one, and that the other countries, many of which went into lockdown, would do worse. Perhaps this, and not herd immunity, is the main reason the authorities are desperately clinging to their strategy. Or perhaps an unwillingness to admit early mistakes and take responsibility for thousands of unnecessary deaths plays into this resistance to change. Nevertheless, the result at this stage is unequivocal.

Social distancing matters. Here is how to do it and how it can help curb the COVID-19 pandemic. USA TODAY

Adopting the Swedish model: Coronavirus doesn't care about public opinion and it still kills

We do believe Sweden can be used as a model, but not in the way it was thought of initially. It can instead serve as a control group and answer the question of how efficient the voluntary distancing and loose measures in Sweden are compared to lockdowns, aggressive testing, tracing and the use of masks.

In Sweden, the strategy has led to death, grief and suffering and on top of that there are no indications that the Swedish economy has fared better than in many other countries. At the moment, we have set an example for the rest of the world on how not to deal with a deadly infectious disease.

In the end, this too shall pass and life will eventually return to normal. New medical treatments will come and improve the prognosis. Hopefully there will be a vaccine. Stick it out until then. And dont do it the Swedish way.

Sigurd Bergmann, Ph.D., Emeritus Professor, Norwegian University of Science and Technology

Dr. Leif Bjermer. Ph.D., Professor, Respiratory Medicine and Allergology, Lund University

Barbara Caracciolo, Ph.D., in Epidemiology

Marcus Carlsson, Ph.D., Associate Professor of Mathematics, Lund University

Dr. Lena Einhorn, Ph.D., in Virology

Dr. Stefan Einhorn, Ph.D.,Professor of Molecular Oncology, Karolinska Institutet

Andrew Ewing, Ph.D., Professor of Chemistry and Molecular Biology, University of Gothenburg

Dr. Manuel Felices, Ph.D.,Head of Endocrine Surgery, NL Hospital

Dr. Jonas Frisn, Ph.D.,Professor of Stem Cell Research, Karolinska Institutet

Marie Gorwa, Ph.D., Professor of Microbiology, Lund University

Dr. ke Gustafsson, Ph.D.,Clinical Microbiology, Uppsala University Hospital

Dr. Olle Isacsson, Ph.D., Professor of Endocrinology, University of Gothenburg

Dr. Claudia Hanson, Ph.D., Associate professor, Global public health, Karolinska Institutet

Dr. Stefan Hanson, Ph.D., International Health, Karolinska Institutet.

Dr. Jan Ltvall, Ph.D., Professor of Clinical Allergy, University of Gothenburg

Dr. Bo Lundbck, Ph.D.,Professor of Epidemiology of Respiratory Diseases, University of Gothenburg

ke Lundkvist,Ph.D., Professor of Virology, Uppsala University

Dr. Cecilia Sderberg-Nauclr, Ph.D.,Professor of Microbial Pathogenesis, Karolinska Institutet

Finn Nilson, Ph.D., Associate Professor of Risk Management, Karlstad University

Andreas Nilsson, Ph.D., Professor of Psychology, University of Gothenburg

Dr. Bjrn Olsen, Ph.D., Professor of Infectious Diseases, Uppsala University

Jens Stilhoff Srensen, Ph.D., Associate Professor, School of Global Studies, University of Gothenburg

Jakob Svensson, Ph.D., Scientific Data Analysis, Max Planck Institute, Greifswald

Dr. Anders Vahlne, Ph.D., Professor of Clinical Virology, Karolinska Institutet

Dr. Anders Wahlin, Ph.D., Professor Emeritus of Hematology, University of Ume

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/opinion/2020/07/21/coronavirus-swedish-herd-immunity-drove-up-death-toll-column/5472100002/

Read this article:

Sweden hoped herd immunity would curb COVID-19. Don't do what we did. It's not working. - USA TODAY

US Offshore Wind Projects Face Make-or-Break Moment – Union of Concerned Scientists

Offshore wind is at a key juncture right now. And your voice can help take it to the next level.

You might have noticed that certain colleagues and I have often blogged excitedly about the brand new (to the US) renewable energy option poised to rise up off our shores. Offshore wind has been a long time in coming, and there is so much enthusiasm in so many quarters.

And no wonder, when you think about all it has to offer. Large amounts of pollution-free and carbon-free electricity generation, close to where its needed. A great complement to solar and land-based wind, and a strong winter resource. Savings for electricity customers, and great economic and jobs potential.

Given all that, a bunch of states have been making it clear that they want to see offshore wind as a substantial part of their electricity supplyand to see the offshore wind industry powering their economies and job growth. And a bunch of project proposals are answering the call.

Several of those projects are slated to be in waters south of Massachusetts and Rhode Island. When Massachusetts issued its first solicitation for offshore wind projects, the winner (with a stunningly low price) was Vineyard Wind, an 800-megawatt projectmeaning enough capacity to provide energy for more than 400,000 Massachusetts homes.

Vineyard Wind had already begun its permitting process, and last summer a federal approval for the project seemed imminentuntil the Trump administration unexpectedly announced that it was going to do another step: a supplement to the draft environmental impact statement to look at cumulative impacts of Vineyard Wind and a bunch other offshore wind projects.

The Bureau of Ocean Energy Management (BOEM), the US Department of the Interior agency in charge of permitting offshore wind and other energy projects off our coasts, recently published that supplemental environmental impact statement (SEIS) for public comment. The SEIS analyzes reasonably foreseeable effects from an expanded cumulative activities scenario for offshore wind development The expanded cumulative scenario includes Vineyard Wind and six other projects that have each gotten to certain stages in their development, for a total of more than 5,000 megawatts. And the SEIS looks at a range of alternatives to the project as proposed.

So why is this moment so important? It matters to the proponents of Vineyard Wind, as a key step toward getting federal approval by the end of this year and getting construction underway soon after. That timing matters to electricity customers, because important federal tax incentives are on the line.

And this moment matters to a lot more people because, given the pandemic, the economic crisis, and the long-standing inequities in our energy systems, we need the savings, the clean air, and the clean electrons that offshore wind can bring. And we need this new industry to be part of the economic rebuilding and job creation in the nearer term.

Getting this process right, right now, matters to all of us who want to see offshore wind happen. Because this step is about the facts of the matter, the findings of the extensive EIS process, including this supplement. But its also about the integrity of the process, about the importance of preserving a central role for science, and about ensuring that BOEM can do what it was made to do, under an administration that hasnt always valued science.

The BOEM SEIS catalogs their findings on possible impacts or benefits in an extensive collection of categories, from habitats and resources (terrestrial, coastal, benthic) to fauna (fish, invertebrates, marine mammals, sea turtles) to people (employment, economics, environmental justice, cultural and historical resources, tourism, fishing, navigation) and more.

BOEM projected major impacts in only a few categories, several of which have already been addressed by changes to the project since their original submission. In all other areas, BOEM deemed the impacts to be moderate, negligible, or even beneficial.

One issue for offshore wind is how we balance competing interests in the marine environment. One answer is to ensure compatibility, to the extent possible.

Vineyard Wind and the four other developers holding offshore wind leases in the Northeast have offered to do that by agreeing to a compromise for the layout of their projects: Instead of optimizing the spacing and location of each turbine, the developers agreed to 1 nautical mile (nm) by 1 nm spacing between turbines, and a fixed grid pattern, east-west and north-south.

Offshore wind lease areas in the Northeast, showing what a standardized 11 east-west/north-south layout might look like. (Turbine locations are illustrative only.) The Vineyard Wind project is in OCS-A 0501.

Putting the turbines that far apart will cut out a lot of clean energy generation (Vineyard Winds own estimate puts that loss at 30%), and thats not something to be taken lightly. It will, though, create more space for boat traffic, including fishing, to make offshore wind turbines better neighbors. And it will offer hundreds of possible routes through the combined projects for traveling east-west, north-south, or diagonally.

The US Coast Guard, in its own analysis of options for safe navigation through offshore wind farms in the area, concluded that a standard and uniform grid pattern with at least three lines of orientation and standard spacing, with 1 nm between turbines, would be appropriate to accommodate vessel transits, traditional fishing operations, and [search and rescue] operations in the area.

One option added to the SEIS for consideration before these recent developments explored adding extra multi-miles-wide transit lanes that would cut through the designated offshore wind areas in several places. The Coast Guards findings and the developers unified commitment to that standard should make it clear that that option, known as Alternative F in the SEIS, is unnecessary. And putting substantially more area off limits to clean energy generation unnecessarily seems like the exact wrong way to go given our need for clean energy.

A sample transit lane through one of the lease areas (Vineyard Winds), showing one of the areas that would be off-limits to turbines under the SEISs Alternative F.

Lucky for us, this comment period is a chance to communicate important considerations like that to BOEM, and to reinforce the importance of both offshore wind and science-based decision making. You can easily and quickly weigh in with written comments to BOEM.

Nows a crucial time, because the comment period ends on July 27. And because US offshore wind has been a long time in coming, and we need it, like, yesterday.

Heres how I put it in my comments to BOEM during one of the virtual hearings on the SEIS earlier this month:

In my almost three decades of working in the power sector, I have never seen an opportunity like were seeing now with offshore wind. The lengthy process to date, and now a strongly supportive SEIS, provide a strong basis for moving forward, with appropriate attention to mitigation. What comes of this process isnt about just one project; its about every project in the queue behind it, and about fidelity to science, and facts, and good decision making.

After years of consideration of offshore wind in these parts, its time for us to act, and to begin to realize the tremendous benefits of offshore wind.

This is your chance to help make it happen.

Photo: Erika Spanger-Siegfried/UCS

Photo: Andy Dingle/Wikimedia Commons

Bureau of Energy Management

Bureau of Ocean Energy Management

Posted in: Energy Tags: Offshore wind

Support from UCS members make work like this possible. Will you join us? Help UCS advance independent science for a healthy environment and a safer world.

Read more here:

US Offshore Wind Projects Face Make-or-Break Moment - Union of Concerned Scientists

SSE plans to build offshore wind farm in Ireland by 2025 – The Irish Times

Scottish utility group SSE has said it hopes to build an offshore wind farm in Ireland by 2025.

The companys Arklow Bank project of at least 520 megawatts was recently added alongside a list of projects to be fast-tracked by the Irish government.

SSE is also eyeing the growing area of floating offshore wind farms that could allow development in vast new areas of the world, such as Japan, Korea and the US West Coast where the seabed is too deep for traditional, fixed installations.

Its inevitable floating wind will come to the fore, Jim Smith managing director of SSE Renewables said.

SSE is planning an expansion of its renewable power business to compete globally for the growing market for massive wind farms. Id like to see us become a global supermajor, Mr Smith said. Who wouldnt if they were running our business?

While its become one of the biggest developers in the UK, the largest market for offshore wind farms, SSE has been slow to branch out of its home territory. With construction set to begin on a number of developments, the company is eyeing growth in a space where seasoned competitors like Denmarks Orsted and Spains Iberdrola are already duking it out for market share.

SSE plans to expand its wind business into two more markets within the next five years, Mr Smith said. Its looking at opportunities in northern Europe, the US and Japan, he added.

With a record-low bid last year to build a giant wind farm off the coast of England, the company has shown that it knows how to win competitive government auctions to build the green power plants at sea.

For offshore wind, SSE would look to partner with a local developer in whatever market they move into to work on a project at an early stage. For wind farms onshore, the company is looking to acquire a developer with a pipeline of projects at various stages of progress and about 1 to 2 gigawatts of capacity, Mr Smith said.

We are continuing to look at a few markets and when the right opportunity comes along we will make a move.

For now, the company is focused on delivering on a huge pipeline of projects. Last year, SSE and Norwegian energy company Equinor won a joint bid to build the worlds biggest wind farm at sea, the 3.6-gigawatt Dogger Bank.

The company also recently made final investment decisions on two other massive wind projects: a 443-megawatt wind farm on the Shetland Islands in Scotland, and the 1.1-gigawatt Seagreen installation off the Scottish coast.

All told, SSE plans to invest 7.5 billion (8.3 billion) by 2025 in projects that will cut greenhouse gas emissions. The utility has said that its balance sheet and divestments can support this growth, and that capital and investment spending on less strategic or less advanced projects will be deprioritised or deferred.

Weve got a lot on our plate to deliver, Smith said. - Bloomberg

See original here:

SSE plans to build offshore wind farm in Ireland by 2025 - The Irish Times

France Opens Public Consultation on Floating Wind Offshore Brittany – Offshore WIND

Frances National Commission for Public Debate (CNDP) has launched a public consultation on future floating wind projects offshore southern Brittany.

The countrys Multiannual Energy Programme (Programmation pluriannuelle de lnergie (PPE)) calls for 8.75 GW of offshore wind capacity to be put out to tender between 2020 and 2028, and for the development of up to 6.2 GW of operating capacity throughout the same period.

Two of those tenders will be for a 250 MW floating wind project off Brittany in 2021, and for a wind farm with the capacity of up to 500 MW from 2024 onward. The projects are planned to have a shared connection to the grid.

The public consultation will run from 20 July to 30 November and is expected to help the Ministry of Ecological Transition decide on the potential site of the projects. The wind farms are expected to be built in an area covering around 600 km2.

The consultations carried out in Brittany over the last several years have already identified areas suitable for the establishment of new offshore wind farms.

Additional topics of the consultation will include the methods for the projects integration into the grid, the maintenance of the wind farms, as well as issues related to the environmental impact of the projects.

Continued here:

France Opens Public Consultation on Floating Wind Offshore Brittany - Offshore WIND

Norway’s offshore oil and gas activity accelerating in 2H 2020 – WorldOil

7/17/2020

OSLO - In the first half of 2020, activity on the Norwegian shelf has been characterized by the coronavirus situation with restrictions on activity, a drop in demand and a declining oil price.

This spring, based on the extraordinary situation in the oil market, the Norwegian government decided to cut oil production as of June and through the rest of the year to contribute toward more rapid stabilization of the oil market than what the market mechanism alone would have ensured.

"There is still a basis for high, long-term value creation on the Norwegian shelf. The political decisions have helped stabilize an extraordinary and demanding situation. The temporary change will contribute to a continued high activity level, on par with what we forecasted before the pandemic and the drop in the oil price," Director General Ingrid Slvberg says.

Following a clarification of the temporary change in the Petroleum Tax Act, two plans for development and operation have been submitted to the authorities for approval. These are the partial electrification of Sleipner and Hod re-development. It is also encouraging that the partners in the Krafla/Askja area have agreed on plans to develop the resources here.

"At the same time, we have noted that exploration activity has declined and will be lower this year than we presumed in January. However, we are experiencing that the companies are not cancelling exploration wells, but rather postponing them until next year," says Slvberg.

Production

At the end of April, the authorities decided to cut Norwegian oil production by 250,000 barrels per day in June and by 134,000 barrels per day in the second half of the year. This was done to help stabilize the oil market faster, which is important out of consideration for sound resource management and the Norwegian economy.

The NPD has assisted the MPE in its work on regulating production. Production from gas and condensate fields, transboundary fields with short remaining production lifetimes and mature fields will not be cut.

Total petroleum production in the first half of 2020 amounted to 115.2 million standard cubic meters (Sm3) of oil equivalents (o.e.). This was distributed across around 49.1 million Sm3 of oil, 56.7 billion Sm3 of gas and 9.4 million Sm3 of NGL and condensate.

In spite of the consequences of Covid 19 and the production regulation, oil production was around 11 million Sm3 higher than in the first half of 2019. This was primarily caused by the first phase of Johan Sverdrup starting full production this spring. The field has proven to deliver beyond initial forecasts.

Gas sales for the first half of 2020 are 4.6 billion Sm3 lower than the corresponding period last year. Gas prices have been low recently, and production is adapted to such market fluctuations.

84 new development wells have been drilled so far this year; this is close to the same level as last year. Drilling wells is the single most important measure toward increasing recovery, which means that it is crucial to drill more wells.

"The companies are doing good work to create value on the fields. This work must continue, fields must be operated efficiently the companies also have to develop, test and utilize new technology to improve recovery and cut emissions", says the NPD's Director for Development and operations, Kalmar Ildstad.

As of 30 June, 88 fields were in production; 66 in the North Sea, 20 in the Norwegian Sea and two in the Barents Sea. Two new fields have come on stream so far this year, Skogul in the North Sea and rfugl in the Norwegian Sea. Both are subsea developments tied into existing fields. Skogul is tied into the Alvheim production and storage vessel via the Vilje field. rfugl, which is being developed in two phases, is tied in to the Skarv production and storage vessel (FPSO). Both fields are operated by Aker BP.

Read the original here:

Norway's offshore oil and gas activity accelerating in 2H 2020 - WorldOil

Why sea fastening is critical to safe and efficient offshore wind installation – Windpower Engineering

By Mark Goalen, Offshore Engineering Director, Houlder Ltd

The offshore wind market is maturing rapidly as the world transitions to cleaner energy. Indeed, the BP Energy Outlook 2019 anticipates significant growth of the sector, suggesting that the percentage of generated wind energy in the renewable market will be more than double by 2040. Meeting this rapid growth in demand presents huge challenges in design, technology and engineering. To make the transition economical, wind farm developers and operators are prioritizing efficiencies in cost and performance across all aspects of the operation.

Sea fastening is the routine practice of fastening cargos to the ship for transport, either to the site of installation or transit from port to port. As component sizes increase, the challenge of transportation becomes more acute. Executed properly, sea fastening enables the safe and efficient transportation of project equipment, minimizing the number of trips required to install the wind farm equipment. This critical stage of the installation process must not be underestimated not least in terms of the value it has the potential to deliver.

Over the last 30 years, the blade diameters of offshore wind turbines have more than quadrupled. Indeed some of the newest blade designs are double the length of a Boeing 747, and it is anticipated that this growth will continue. As experience is gained, and the technology develops, the turbines get larger to generate more power.

As the components increase in size and at a significant rate, the industry is pondering the optimum design for the next generation of installation vessel.In the meantime, however, the existing fleet is being pushed to the limit.Particularly as there is commercial pressure to maximize the amount of equipment on the vessel per trip to help decrease the overall cost of offshore wind farm installation. This significantly increases the project risks associated with transportation and installation.

The importance of sea fastening in this context is often undervalued this is not as simple as a standard offshore container sitting on a deck well within the allowable variable deck load. For todays wind farm installations, the components do not only differentiate in size and weight, but also shape. The blades need to be transported in racks, the monopiles in cradles, and the towers on grillages; all of which must be designed to fit. This is sea fastening, but not as we knew it.

When particularly large equipment is secured to a vessel, the loading conditions must be checked to ensure the vessel remains stable and within the operationally compliant restraints of draught and trim.

Additionally, the weight and height of these components adjusts the vessels motion characteristics. Therefore, bespoke vessel motion must be derived to determine the forces the equipment will impart into the hull as the vessel rolls and pitches while at sea. The length of the blades and sometimes monopiles means that they can overhang the edges of the hull, meaning additional green water analysis may be required.

The structural analysis, design and engineering work follows confirmation of stability and the determination of vessel motions. It is essential that the structural interface for each piece of equipment is designed to transmit the loads into the vessel structure without overstressing and damaging the hull or the connecting interface.

For jack up vessels, it is also important to check hull strength in the jacked-up condition, and that the forces pushing down on each of the legs does not exceed the allowable seabed limitations. The leg forces can vary significantly when the vessel crane lifts the wind farm components, and so several scenarios must be considered.

Experienced, practical analysis is essential to ensure proper securing and sea fastening of high-value cargoes to guarantee a projects success. Developing an offshore wind farm involves specific and expert engineering, from concept design to installation, into operation and finally decommissioning. Every element is closely interlinked and therefore decisions must not be taken in isolation the wider picture must always be considered.

This is why analytical capability alone is insufficient; structural analysis is just one piece of the puzzle. There is a seamless chronology between understanding stability and vessel motions before then delivering on design. For example, what are the practicable options when an allowable vessel limit is exceeded or is so-close to exceedance that further calculation is required to prove it is acceptable? Every decision has a knock on effect, which is why throughout the entire process considerable experience is needed across each and every element to engineer reliable solutions which facilitate safe, timely, and cost-efficient delivery.

Progress necessitates change in the swiftly advancing offshore wind space, particularly as global societal pressure increases the move to cleaner energy sources, while development costs continue to be driven down. To safeguard investment, protect assets and maximize efficiencies, integrated design and engineering remains critical in navigating the evolving challenges of this swiftly emerging sector.

Houlder has completed multiple fixed bottom offshore wind sea fastening projects for various clients. During the course of these projects it has designed the structural interfaces between all of the primary offshore wind components and the vessel tower grillages, blade racks, substructures, TP grillages, monopile cradles as well as various ancillary equipment that goes along with the mobilization. Each project is different and presents its own unique challenges.

When designing the primary support structure for any of the main components, the main interface is usually a straight forward process.The challenge is transferring the loads into the vessel to avoid underdecks strengthening or fatigue issues while working within fixed vessel parameters such as crane reach and height, loading condition ballast limits, and avoiding clashes with areas that require access or walkways for safe operations, etc. Careful consideration to each limitation, and a multidisciplinary team that can work effectively together and in parallel is the key to a successful outcome within the planned timeframe.

There are always additional requirements that present themselves where an efficient engineering team can add real value to the project. Houlder has designed lifting arrangements (including spreader beam) to improve mobilization times of blade rack substructures that were not originally designed to be lifted in one unit. It has also added and repositioned boat landing platforms, and relocated crane boom rests, for example. In addition to back deck equipment, Houlder has relocated life rafts and FRCs to avoid project equipment and is familiar with the requirements for class approval of safety-related equipment.

Houlder has also provided quick responses to queries during mobilization. Wrong bolt grades being delivered, slings that are shorter, and a lower SWL than requested, uneven decks, are all things that have arisen and been resolved quickly without holding up the mobilization.

Go here to see the original:

Why sea fastening is critical to safe and efficient offshore wind installation - Windpower Engineering

BoldWind Offloads First Offshore Wind Cargo in Port of Esbjerg – Offshore WIND

The new heavy load deck carrier chartered by MHI Vestas, MV BoldWind, has made its first port call in Esbjerg to unload wind turbine blades for the Moray East offshore wind farm.

The vessel, owned and operated by United Wind Logistics (UWL) and hired by MHI Vestas under a long-term charter agreement, embarked on its maiden voyage from China to Europe after it was delivered this May.

MV BoldWind was built by Jiangsu Zhenjiang Shipyard in Zhenjiang, which is expected to soon deliver another such vessel to UWL, MV BraveWind, launched in mid-June.

The MV BraveWind has also been chartered by MHI Vestas.

The 148.5-metre deck carriers, equipped with diesel electric propulsion, have a deadweight of 10,000 tonnes, a deck length of 128 metres, and a width of 28 metres.

UWLs shipbuilding contract with Zhenjiang Shipyard comprises an option for two additional vessels.

Continue reading here:

BoldWind Offloads First Offshore Wind Cargo in Port of Esbjerg - Offshore WIND

Probe utilitys offshore accounts The Manila Times – The Manila Times

A lawyer from Iloilo City has vowed to seek an investigation of the findings of an international group of journalists that the Panay Electric Co. (PECO) and its owners, the Cacho family led by its patriarch Luis Miguel Cacho, opened three offshore companies in the Bahamas with the help of a Singapore-based in vestment firm.

PECO used to distribute electricity in Iloilo City.

The offshore accounts owned by PECO and the Cacho family were discovered in an international investigation of two databases that had been fed for nearly 30 years by two companies: Singapore-based Portcullis TrustNet and British Virgin Islands (BVI)-based Commonwealth Trust Ltd.

Lawyer Zafiro Lauron said he would ask the Anti-Money Laundering Council to open an investigation of the offshore bank accounts of the Cacho family and PECO.

I will pursue this case on behalf of Ilonggos who suffered from paying electricity bills almost double of those being paid by people in Metro Manila, he added.

The International Consortium of Investigative Journalists (ICIJ) listed PECO as one of the owners of two companies while Luis Miguel Cacho owned one investment company, all registered in the BVI, a tax haven favored by wealthy families.

The ICIJ, a global network of more than 190 investigative journalists in more than 65 countries, came out with batches of documents of secret registration of paper companies in tax havens all around the world.

According to the consortium, among the documents found in the data leaked to the group called the Offshore Leaks Papers were thousands of documents listing the paper companies that were registered in the BVI by Portcullis TrustNet Fund Services Ltd., a company owned by Singapore-based Portcullis Services Pte. Ltd.

The ICIJ found that PECO and members of the Cacho family registered at least three companies in the BVI at a period when Iloilo City officials and Ilonggos demanded that PECO account for the high levels of profits that it had declared for its shareholders.

The ICIJ web page showed that the late Luis Miguel Cacho registered a company called the Costa Group Investments Ltd. on April 11, 2000, with an address listed as Portcullis Trustnet Chambers, PO Box 3444 Road Town Tortola, BVI.

Listed as members of its board of directors were Luis Miguel Ayesa Cacho, also corporate secretary, Jose Maria Cacho and William Michael Valtos Jr.

Luis Miguel was also the president and chief operating officer of PECO, while his son Marcelo is PECOs head of public engagement and government affairs.

According to the ICIJ, PECO also set up two other companies in the BVI.

The utility firm lost its franchise to distribute power in Iloilo City early this year.

Continue reading here:

Probe utilitys offshore accounts The Manila Times - The Manila Times

Partrac and Team Working on Arklow Bank 2 – Offshore WIND

Partrac, MetOceanWorks and Cooper Marine Advisors are carrying out a detailed assessment of the geomorphology of SSE Renewables Arklow Bank Wind Park Phase 2 offshore wind project.

The consortium partners are currently in the second stage of their project, following the completion of the first round of work at the end of 2019.

Last year, the team provided a comprehensive literature review, an initial phase of numerical modelling and recommendations for detailed site investigations, including metocean and geophysical surveys.

Now, in Stage 2, Partrac and partners are utilising the survey data to provide local validation of the modelling tools which will be used to support a long-term assessment of the lease area, export cable route and surrounding areas.

The geomorphological assessment compliments our engineering work streams, allowing us to make decisions with increased knowledge and therefore confidence. We are pleased to be working with the Partrac consortium toward delivery of Stage 2 of this exciting project, said John Davidson, SSE Offshore Geotechnical Engineer.

In mid-July, Partrac informed that it provided metocean survey and consultancy services for three offshore wind projects currently under development in Ireland.

The Arklow Bank Wind Park Phase 2, located off the East Coast of County Wicklow in the Irish Sea, has a consented minimum installed capacity of 520 MW.

The offshore wind farm is planned to be built by 2025.

Continued here:

Partrac and Team Working on Arklow Bank 2 - Offshore WIND

Vattenfall Reports Lower Q2 Wind Figures, Announces Resignation of CEO – Offshore WIND

Vattenfalls results for the second quarter of the year show a decrease in net sales and underlying operating profit of its wind business, compered to the same period in 2019.

The company posted the Q2 results on 21 July, stating that the decrease is due to lower wind speeds, lower electricity prices and lower availability, mainly in offshore wind.

Vattenfalls wind unit had a net sales of SEK 2.2 billion (approximaterly EUR 215 million) in Q2, while in the same period last year this stood at SEK 2.76 billion (approx. EUR 270 million). Second quarters underlying operating profit was SEK -144 million (approx. EUR -14 million); in Q2 2019 it was SEK 365 million (apprpx. EUR 35 million).

Looking at the first six months of the year, net sales and underlying operating profit for the wind energy unit increased as a result of new capacity and higher production from strong winds early in the year. The new capacity that contributed to higher first half figures is mainly attributed to the Horns Rev 3 offshore wind farm in Denmark. The H1 results were also partly offset by lower electricity prices.

On the same day it reported its financial results, Vattenfall also announced its President and CEO Magnus Hall decided to leave the company.

Hall, who has held the position for the past six years, will resign no later than 31 January 2021.

The Board will now start the recruitment process for a new President and CEO with the goal to make a smooth succession. Vattenfalls existing strategy and financial targets remain unchanged, said Lars G Nordstrm, Vattenfalls Chairman of the Board of Directors.

Go here to see the original:

Vattenfall Reports Lower Q2 Wind Figures, Announces Resignation of CEO - Offshore WIND

Offshore Supply Vessel (OSV) Market Size Technological Advancement And Growth Analysis With Forecast To 2025 – Cole of Duty

Up Market Research (UMR), a prominent market research firm in its own industry, has published a detailed report on Global Offshore Supply Vessel (OSV) Market. This market research report provides comprehensive and in-depth analysis on the market which can possibly help an enterprise to identify lucrative opportunities and assist them with fabricating creative business strategies. The market report provides information about the current market scenario regarding the global supply and demand, key market trends and opportunities in the market, and challenges and threats faced by the industry players.

The Offshore Supply Vessel (OSV) market report talks about the competitive scenario among the industry players and imparts aspiring and emerging industry players with the future market insights in a detailed manner. This market report includes crucial data and figures which are structured out in a concise yet understandable manner. The research report covers the updates on the government regulations and policies which illustrates key opportunities and challenges of the market. Up Market Research (UMR) has been monitoring the market since few years and collaborated with eminent players of the industry to give better insights on the market. It has conducted vigorous research and implied robust methodology to provide accurate predictions about the market.

You can buy the complete report on @ https://www.upmarketresearch.com/buy/offshore-supply-vessel-market-research-2019

Impacts of Advancements and COVID-19 on the market.

Amidst the COVID-19, few segments of the market have witnessed a disruption due to the gap in supply and demand which has impacted the growth of the Offshore Supply Vessel (OSV) market. Along with this, the latest advancements have changed the market dynamics of the market. This research report covers the wide-range analysis of the COVID-19 impact to the industry and gives out insights on the change in the market scenario due to the advancements.

Request a Sample report before buying the report @ https://www.upmarketresearch.com/home/requested_sample/64293

Market Segmentation

Some of the major companies that are covered in the report.

Edison ChouestTidewaterBourbon OffshoreGulf MarkMaersk Supply ServiceFarstad ShippingHornbeckSwiresDOFDeep Sea SupplyHarvey GulfSeacor MarineSiem OffshoreSolstad OffshoreCoslIsland OffshoreHavilaPACC Offshore Service

Note: Additional companies

Based on the type, the market is segmented into

AHTSPSV

Based on the application, the market is segregated into

Oil and Gas Exploration and ProductionOffshore ConstructionMilitary

Based on the geographical location, the market is segregated into

Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

Up Market Research (UMR) provides yearly updates on the Offshore Supply Vessel (OSV) market that assist the clients to stay ahead in the competitive space.

Why one should buy this Offshore Supply Vessel (OSV) Report?

The market research report provides all valuable constituents of the market such as revenue growth, product pricing & analysis, growth potential, and guidelines to tackle the challenges in the market. The report covers all the crucial mergers & acquisitions, partnerships, and collaborations that created further created opportunities or in some cases, challenges for the industry players.

This report includes latest product news, advancements, and updates from the prominent player of the industry that has leveraged their position in the market. It also provides business strategies implemented by the key players and yardstick to arrive on informed business decisions. Moreover, it gives insights on the consumer behavior patterns that can help the enterprise to curate the business strategies accordingly.

Up Market Research (UMR) bestows the clients with the specialized customized options related to the regional analysis, company analysis, and product analysis, among others.

Complete Table Content of the Market

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Offshore Supply Vessel (OSV) Market Overview

Offshore Supply Vessel (OSV) Supply Chain Analysis

Offshore Supply Vessel (OSV) Pricing Analysis

Global Offshore Supply Vessel (OSV) Market Analysis and Forecast by Type

Global Offshore Supply Vessel (OSV) Market Analysis and Forecast by Application

Global Offshore Supply Vessel (OSV) Market Analysis and Forecast by Sales Channel

Global Offshore Supply Vessel (OSV) Market Analysis and Forecast by Region

North America Offshore Supply Vessel (OSV) Market Analysis and Forecast

Latin America Offshore Supply Vessel (OSV) Market Analysis and Forecast

Europe Offshore Supply Vessel (OSV) Market Analysis and Forecast

Asia Pacific Offshore Supply Vessel (OSV) Market Analysis and Forecast

Middle East & Africa Offshore Supply Vessel (OSV) Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, please reach out to us @ https://www.upmarketresearch.com/home/enquiry_before_buying/64293

About the Company

Up Market Research (UMR) is the largest aggregator of the market research report in the industry with more than 800 global clients. The company has extensively invested in the research analysts training and programs to keep the analyst tapped with the best industry standards and provide the clients with the utmost experience. Our dedicated team has been collaborating with the industry experts to give out the precise data and figures related to the industry. It conducts primary research, secondary research, and consumer surveys to provide an in-depth analysis of the market. The market research firm has worked in several business verticals and has been successful to earn high credentials over the time.

Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Website https://www.upmarketresearch.comAddress 500 East E Street, Ontario, CA 91764, United States.

Link:

Offshore Supply Vessel (OSV) Market Size Technological Advancement And Growth Analysis With Forecast To 2025 - Cole of Duty

Global Offshore Cable Market 2020: Industry, Size, Share, Demands, Growth, Opportunities, Trends Analysis and Forecast Till 2025:::ABB, Nexans, NKT,…

Trending Offshore Cable Market 2020: COVID-19 Outbreak Impact Analysis

Chicago, United States The Offshore Cable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations

The Offshore Cable market report 5 Years Forecast [2020-2025] focuses on the COVID19 Outbreak Impact analysis of key points influencing the growth of the market. The intelligence report prepared contains details on the leading players of the Global Offshore Cable Market, along with various depending aspects related and associated with the market. Profile the Top Key Players of Offshore Cable, with sales, revenue and global market share of Offshore Cable are analyzed emphatically by landscape contrast and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated. The Offshore Cable market business development trends and selling channels square measure analyzed. Offshore Cable industry research report enriched on worldwide competition by topmost prime manufactures which providing information such as Company Profiles, Gross, Gross Margin, Capacity, Product Picture and Specification, Production, Price, Cost, Revenue and contact information.The report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the Offshore Cableindustry. Growth of the overall Offshore Cablemarket has also been forecasted for the period 2020-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

>>>>>>This Report Covers Leading Companies Associated in Worldwide Offshore Cable Market: [ ABB, Nexans, NKT, Prysmian, General Cable, Sumitomo Electric Industries, Parker Hannifin, LS Cable & System, TPC Wire & Cable, Fujikura, JDR Cable Systems, Able, Brugg Cables, LEONI, Fujikura ]>>>>>>To know How COVID-19 Pandemic Will Impact This Market/Industry | Request a sample copy of the Offshore Cable Market report:

Key Issues Addressed by Offshore Cable Market: The Offshore Cable report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. This report provides an in-depth analysis of parent company market trends, macroeconomic indicators and dominant factors, and market attractiveness by segment.

Our exploration specialists acutely ascertain the significant aspects of the global Offshore Cable market report. It also provides an in-depth valuation in regards to the future advancements relying on the past data and present circumstance of Offshore Cable market situation. In this Offshore Cable report, we have investigated the principals, players in the market, geological regions, product type, and market end-client applications. The global Offshore Cable report comprises of primary and secondary data which is exemplified in the form of pie outlines, Offshore Cable tables, analytical figures, and reference diagrams. The Offshore Cable report is presented in an efficient way that involves basic dialect, basic Offshore Cable outline, agreements, and certain facts as per solace and comprehension.

Key point summary of the Offshore Cable market Report:

1) Examining the overall market, underlining the recent trends and SWOT analysis2) Offshore Cable Market scenario, focused on the growth opportunities in the market in the coming years3) Analysis of the different market segments, including qualitative and quantitative research and studies the impact of both economic and non-economic factors4) Inspection of the market at regional and global levels focusing on the demand and supply factors affecting the growth of the Offshore Cable market.5) Market size (USD Million) and volume (Units Million) statistics for all market segment and sub-segment6) Competitive analysis with Offshore Cable market share of leading market players, shedding light on project launches and tactical approaches implemented by the players in the last five years7) Extensive company profiling comprising of the product offerings, key financial facts and figures, recent developments, SWOT analysis, and strategic initiatives by the major firms in the Offshore Cable market

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Competitive Landscape:

The competitive analysis of major market players is another notable feature of the Offshore Cable market report; it identifies direct or indirect competitors in the market.

The Offshore Cable market report provides answers to the following key questions:

At what rate is the Offshore Cable market expected to grow in size in the forecast period? What are the key factors influencing the global Offshore Cable market growth? Which significant market trends are driving the growth of the global Offshore Cable market? Which factors are the determinants of the market shares of the leading geographies across the globe? Who are the leading participants in the industry and what are the strategies adopted by them in the global Offshore Cable market? What are the opportunities and challenges encounters by vendors in the global Offshore Cable market? Which trends, drivers and challenges are affecting the growth of the industry? What is the outcome of the PESTEL analysis of the global Offshore Cable market?

Analysis of Global Offshore Cable Market: By Type Inter-array CableExport Cable

Analysis of Global Offshore Cable Market: By Application Offshore Wind TurbineOil and Gas Drilling

Offshore Cable Market Regional Analysis Includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (the United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

The Research Study Focuses on:

Market Position of Vendors Vendor Landscape Competitive scenario Manufacturing Cost Structure Analysis Recent Development and Expansion Plans Industry Chain Structure>>> Make an enquiry before buying this report @ https://www.reporthive.com/request_customization/2326060

Why Report Hive Research?:

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc.

Get in Touch with Us :

Report Hive Research500, North Michigan Avenue,Suite 6014,Chicago, IL 60611,United StatesWebsite: https://www.reporthive.comEmail: [emailprotected]Phone: +1 312-604-7084

See original here:

Global Offshore Cable Market 2020: Industry, Size, Share, Demands, Growth, Opportunities, Trends Analysis and Forecast Till 2025:::ABB, Nexans, NKT,...

New Road Map for Murphy Administrations Offshore Wind Ambitions – NJ Spotlight

According to the plan, offshore wind will supply 23% of the electricity to customers throughout the state by 2050.

The state has developed a road map for how it will build 7,500 megawatts of offshore wind capacity off the coast within 15 years, a goal the Murphy administration says will help New Jersey become a hub for the fast-growing sector.

The draft Offshore Wind Strategic Plan (OWSP) offers no new major revelations, but instead focuses on a series of priorities the state intends to follow in trying to build a robust offshore wind industry here while protecting its environmental and natural resources, as well as commercial and recreational fisheries.

Offshore wind is viewed as a critical component of the states efforts to combat climate change and seen as key to help grow a green economy in New Jersey and provide thousands of high-paying jobs. By 2050, offshore wind will supply 23% of the electricity to customers throughout the state, according to the 501-page plan.

The development of New Jerseys offshore wind infrastructure will create thousands of high-quality jobs, bring millions of investment dollars to our state, and make our state a global leader in offshore wind development and deployment, Gov. Phil Murphy said in a preamble to the draft plan.

The clean-energy goal, however, has raised concerns among consumer advocates and business groups, who fear the transition to cleaner energy will spike what they view as already steep energy bills for residents and businesses in New Jersey.

The draft plan does not address potential costs in detail, although it acknowledges the upgrading of port facilities around New Jersey to serve the offshore wind sector will require hundreds of millions of dollars in investments.

The goal of the OWSP is to ensure competition, competitive pricing, net economic benefit, environmental and natural resource protection and the overall best value for New Jersey ratepayers, according to the plan.

Nevertheless, it does not offer a rough estimate of what it will take to build out the 7,500 MW offshore capacity and it does not provide associated costs for that process, including the numerous financial incentives mentioned in the draft, the cost of upgrading port facilities, and numerous studies it suggests need to be undertaken to protect natural resources and fisheries.

We support offshore wind, said Dennis Hart, executive director of the Chemistry Industry Council of New Jersey, but at some point, the state Board of Public Utilities has promised its analysis of what it will cost ratepayers. So far, we havent seen anything.

BPU President Joseph Fiordaliso, at the agencys bimonthly meeting on Wednesday, described the draft as providing a comprehensive road map to achieving the goal of 7,500 MW of offshore wind by 2035, while providing the best value to ratepayers.

The draft offers a series of recommendations focusing on five priorities: protection of environmental and natural resources; maintaining viable commercial and recreational fisheries; building a supply chain and training a workforce; identifying potential ports and harbors to serve the sector; and addressing the transmission infrastructure to bring power from the offshore wind farms to residents and businesses.

The latter issue has been controversial with offshore wind developers, so far, opting to build those lines to points on land. Others advocate a so-called backbone transmission system that would allow wind energy to be wheeled up and down the coast. The draft recommends further study on the issue.

The draft suggests two ports will have significant roles in early development of offshore wind the New Jersey Wind Port in Salem County adjacent to the nuclear units there and Paulsboro. They will be especially critical in the rollout of the states first offshore wind farm by rsted 15 miles from Atlantic City. The 1,100 MW Ocean Wind project is not expected to be operating until 2024.

The BPU is expected to seek an additional solicitation for offshore wind projects later this year.

Read the original post:

New Road Map for Murphy Administrations Offshore Wind Ambitions - NJ Spotlight

RWA: Unlicensed offshore websites pose major threat to responsible gambling in Australia – Gambling Insider – In-depth Analysis for the Gaming…

Responsible Wagering Australia (RWA) has warned that an increase in online gambling poses a major threat to responsible gambling in Australia if fuelled by unlicensed overseas websites.

With various reports of a rise in gambling spending in Australia during the pandemic, the online gambling operator association believes they dont paint the full picture.

Instead, RWA is concerned that much of the online gambling growth has been taken up by unlicensed offshore betting websites, and many people are walking around with an unlicensed casino in their pocket.

RWA CEO Brent Jackson, said: Historical consumer credit data is being used to create alarmist reports that gambling has surged during the COVID crisis.

Without context people assume that increases in online gambling during COVID automatically mean an increase in overall gambling activity. This isnt the industry experience, and credible data sources arent suggesting that either.

Online casinos and pokies operate illegally in Australia despite hundreds of overseas websites being accessible with the click of a button.

While its against the law for businesses to provide these betting games to the Australian market, it isnt actually illegal for Australians to access them, and this puts consumers (including children and vulnerable people) at major risk.

Last month at ICE Asia Digital, Office of Liquor and Gaming Regulation (OLGR) Queensland executive director, Michael Sarquis, said online gambling in Australia grew by 140% during the coronavirus pandemic.

Read this article:

RWA: Unlicensed offshore websites pose major threat to responsible gambling in Australia - Gambling Insider - In-depth Analysis for the Gaming...

Consortium in talks to advance Barryroe oil and gas project offshore Ireland – Offshore Oil and Gas Magazine

(Map courtesy Providence Resources)

Offshore staff

DUBLIN, Ireland Providence Resources is in fam-out discussions with SpotOn Energy on exploration license SEL1/11 in the Celtic Sea offshore southern Ireland.

The license includes the Barryroe oil and gas field. SpotOn Energy has confirmed that binding term sheets are now in place with six consortium participants in the fields appraisal and development project, and that it is working with Providence to finalize the work program.

Once agreement has been reached, SpotOn Energy will manage the Barryroe development.

The consortium comprises industry service and supply companies said to hold experience in projects similar to Barryroe, a conventional shallow-water development.

Providence CEO Alan Linn said: Barryroe is one of the largest undeveloped oil and gas fields in Europe When fully developed [it] can provide Ireland with locally produced long-term energy security.

07/20/2020

Read the original:

Consortium in talks to advance Barryroe oil and gas project offshore Ireland - Offshore Oil and Gas Magazine